Zaloguj się

Gotowe bibliografie tematyczne / Diagnosis and monitoring of bladder cancer / Książki

Kliknij ten link, aby zobaczyć inne rodzaje publikacji na ten temat: Diagnosis and monitoring of bladder cancer.

Książki na temat „Diagnosis and monitoring of bladder cancer”

Autor: Grafiati

Data publikacji: 29 marca 2025

Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych

Wybierz rodzaj źródła:

Sprawdź 50 najlepszych książek naukowych na temat „Diagnosis and monitoring of bladder cancer”.

Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.

Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.

Przeglądaj książki z różnych dziedzin i twórz odpowiednie bibliografie.

1

J, Droller Michael, red. Bladder cancer: Current diagnosis and treatment. Totowa, N.J: Humana Press, 2001.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

2

Nilsson, William E. Bladder cancer: Etymology, diagnosis, and treatments. Hauppauge, N.Y: Nova Science Publishers, 2010.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

3

Lee, Cheryl T. Bladder cancer: Diagnosis, therapeutics, and management. New York, NY: Humana Press, 2010.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

4

N, Syrigos Konstantinos, i Skinner Donald G, red. Bladder cancer: Biology, diagnosis, and management. Oxford: Oxford University Press, 1999.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

5

A, Stoll Basil, red. Screening and monitoring of cancer. Chichester: Wiley, 1985.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

6

Hayat, M. A. Methods of Cancer Diagnosis, Therapy, and Prognosis: Ovarian Cancer, Renal Cancer, Urogenitary tract Cancer, Urinary Bladder Cancer, Cervical Uterine Cancer, Skin Cancer, Leukemia, Multiple Myeloma and Sarcoma. Dordrecht: Springer Science+Business Media B.V., 2010.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

7

G, Maldonado Jonathon, i Cervantes Mikayla K, red. Small cell carcinomas: Causes, diagnosis and treatment. Hauppauge, N.Y: Nova Science, 2009.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

8

Maldonado, Jonathon G. Small cell carcinomas: Causes, diagnosis and treatment. New York: Nova Biomedical Books, 2009.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

9

Galsky, Matthew D. Dx/Rx: Genitourinary oncology : cancer of the kidneys, bladders, and testis. Wyd. 2. Sudbury, Mass: Jones & Bartlett Learning, 2012.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

10

Giampietro, Gasparini, i Hayes Daniel 1951-, red. Biomarkers in breast cancer: Molecular diagnostics for predicting and monitoring therapeutic effect. Totowa, N.J: Humana Press, 2006.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

11

Maldonado, Jonathon G., i Mikayla K. Cervantes. Small cell carcinomas: Causes, diagnosis and treatment. New York: Nova Biomedical Books, 2009.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

12

Canada. Health Canada. Evaluation Indicators Working Group. Guidelines for monitoring breast screening program performance: Report from the Evaluation Indicators Working Group. Wyd. 2. [Ottawa]: Public Health Agency of Canada, 2007.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

13

Australian Institute of Health and Welfare. National Bowel Cancer Screening Program monitoring report, 2008: 7 August 2006-30 June 2008. Canberra: Australian Institute of Health and Welfare, 2007.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

14

Barentsz, Jelle O. Magnetic resonance imaging of carcinoma of the urinary bladder. Dordrecht: Kluwer Academic Publishers, 1990.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

15

Australia, BreastScreen. BreastScreen Australia monitoring report / the Australian Institute of Health Welfare and the Australian Government Department of Health and Aging for the BreastScreen Australia Program. Canberra: Australian Institute of Health and Welfare, c2003., 2003.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

16

Group, Canada Health Canada Evaluation Indicators Working. Report from the Evaluation Indicators Working Group: Guidelines for monitoring breast screening program performance. [Ottawa]: Health Canada, 2002.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

17

Canada. Health Canada. Evaluation Indicators Working Group. Report from the Evaluation Indicators Working Group: Guidelines for monitoring breast screening program performance. Wyd. 2. [Ottawa]: Public Health Agency of Canada, 2007.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

18

E, Matouschek, European Organization for Research on Treatment of Cancer. Genito-Urinary Tract Cancer Cooperative Group. i World Health Organization. Collaborating Centre for Urinary Bladder and Prostatic Cancer, red. Endourology: [proceedings of the Third Congress of the International Society of Urologic Endoscopy, together with World Health Organization (W.H.O.) Collaborating Centre for Urinary Bladder and Prostatic Cancer and with European Organization of Research on the Treatment of Cancer (E.O.R.T.C.) Genito-Urinary Tract Cancer Cooperative Group; August 26-30, 1984, Karlsruhe, Federal Republic of Germany]. Baden-Baden: BuA-Verlag Werner Steinbrück, 1985.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

19

Public Health Agency of Canada. Centre for Chronic Disease Prevention and Control i Agence de santé publique du Canada. Centre de prévention et de contrôle des maladies chroniques, red. Report from the evaluation indicators working group: Guidelines for monitoring breast screening program performance = Rapport du groupe de travail sur les indicateurs d'évaluation : lignes directrices pour la surveillance de la performance des programmes de dépistage du cancer du sein. Wyd. 2. [Ottawa, Ont.]: Public Health Agency of Canada = Agence de santé publique du Canada, 2007.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

20

Lee, Cheryl T., i David P. Wood. Bladder Cancer. Springer, 2011.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

21

Syrigos, Konstantinos, i Konstantinos N. Syrigos. Bladder Cancer: Biology, Diagnosis, Management. John Wiley & Sons Inc, 2001.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

22

Bladder Cancer: Diagnosis and Clinical Management. Wiley-Interscience, 2015.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

23

Bladder Cancer: Current Diagnosis and Treatment. Humana Press, 2012.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

24

Schoenberg, Mark P., Seth P. Lerner i Cora N. Sternberg. Bladder Cancer: Diagnosis and Clinical Management. Wiley & Sons, Incorporated, John, 2015.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

25

Droller, MD Michael J. Bladder Cancer: Current Diagnosis and Treatment. Humana, 2010.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

26

Schoenberg, Mark P., Seth P. Lerner i Cora N. Sternberg. Bladder Cancer: Diagnosis and Clinical Management. Wiley & Sons, Incorporated, John, 2015.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

27

Lee, Cheryl T., i David P. Wood. Bladder Cancer: Diagnosis, Therapeutics, and Management. Humana Press, 2012.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

28

Schoenberg, Mark P., Seth P. Lerner i Cora N. Sternberg. Bladder Cancer: Diagnosis and Clinical Management. Wiley & Sons, Limited, John, 2015.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

29

Silverman, Debra T., Stella Koutros, Jonine D. Figueroa, Ludmila Prokunina-Olsson i Nathaniel Rothman. Bladder Cancer. Oxford University Press, 2017. http://dx.doi.org/10.1093/oso/9780190238667.003.0052.

Pełny tekst źródła

Streszczenie:

In the United States, an estimated 74,000 new cases of bladder cancer and 16,000 deaths occur annually. Because of favorable survival, approximately 578,000 persons are alive after diagnosis. Recurrence after treatment is common, necessitating lifelong surveillance and care, making bladder cancer the most costly malignancy from diagnosis to death. The median age at diagnosis has increased from 67 years in 1980 to 73 years in 2008–2012. Incidence rates rise dramatically with age, suggesting that as the US population ages, the burden of bladder cancer in the United States will continue to grow. Worldwide over 1.3 million cases are estimated to occur annually. Cigarette smoking is the principal known cause of bladder cancer, along with various chemical exposures. Recent studies suggest that, over the past two decades, the risk for current smokers has increased from three times the risk of nonsmokers to about four to five times the nonsmoker risk.

Style APA, Harvard, Vancouver, ISO itp.

30

(Editor), Konstantinos N. Syrigos, i Donald Skinner (Editor), red. Bladder Cancer: Biology, Diagnosis and Management (Oxford Medical Publications). Oxford University Press, USA, 1999.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

31

Teoh, Jeremy, i Daniele Castellani, red. Recent Advances in Bladder Cancer Diagnosis and Treatment. Frontiers Media SA, 2022. http://dx.doi.org/10.3389/978-2-88976-080-0.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

32

Droller, Michael J. Bladder Cancer: Current Diagnosis and Treatment (Current Clinical Urology). Humana Press, 2001.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

33

Ziglioli, Francesco, i Umberto Maestroni. Modern Approach to Diagnosis and Treatment of Bladder Cancer. IntechOpen, 2021.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

34

Bladder Cancer: Diagnosis, Therapeutics, and Management (Current Clinical Urology). Humana Press, 2008.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

35

Bellmunt, Joaquim. Bladder Cancer, an Issue of Hematology/Oncology Clinics of North America. Elsevier, 2015.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

36

Chapman, Hannah, i Christine Elwell. Renal and bladder cancer. Redaktorzy Patrick Davey i David Sprigings. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199568741.003.0167.

Pełny tekst źródła

Streszczenie:

This chapter addresses the diagnosis and management of bladder and renal cancers. In the UK, bladder cancer is the fourth most common cancer in men, and the eighth most common cancer in women. Bladder cancer arises from the bladder urothelium, and is typically a papillary transitional cell carcinoma. Chronic infection with the parasite Schistosoma haematobium is associated with squamous cell carcinoma of the bladder, and is most prevalent in Egypt and sub-Saharan Africa. Renal cancer accounts for 3% of cancers in adults in the UK and, in most cases, is a renal cell carcinoma arising from proximal renal tubule epithelium. A further 5%–10% of renal cancers are transitional cell (urothelial) carcinomas of the renal pelvis. Benign kidney tumours, such as cysts, are also common.

Style APA, Harvard, Vancouver, ISO itp.

37

Brinkman, Maree, i Maurice Zeegars. Screening for bladder cancer. Redaktor James W. F. Catto. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199659579.003.0073.

Pełny tekst źródła

Streszczenie:

Bladder cancer (BC) is one of the most common urological malignancies and ranks ninth among all cancers worldwide. While screening has the potential to detect early cases of BC and reduce disease specific mortality, to date there are no routine screening programmes of asymptomatic individuals conducted anywhere in the world. There are however, a range of tests and procedures available for the detection and subsequent diagnosis of BC for select individuals presenting with urological symptoms and who are at increased risk of the disease.This chapter provides an overview of the traditional screening tools used for the detection of BC, such as urinalysis for haematuria and urinary cytology, as well as a brief description of follow-up procedures including cystoscopy, imaging, and treatment modalities.

Style APA, Harvard, Vancouver, ISO itp.

38

Bryant, Richard J., i James W. F. Catto. General overview of bladder cancer. Redaktor James W. F. Catto. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199659579.003.0074.

Pełny tekst źródła

Streszczenie:

Bladder cancer (BC) is a common malignancy and is one of the most expensive to manage. This tumour typically affects middle-aged and elderly patients and is more common in men. These demographics reflect the aetiological links between BC and tobacco smoking and occupational exposure to carcinogens. While the presenting symptom of BC is usually painless visible haematuria, around one-quarter of tumours present with irritative voiding symptoms, recurrent or antibiotic-refractory urinary tract infections, non-visible haematuria, or are found by chance during the investigation of unrelated symptoms. As such, these urological symptoms require urgent investigation in patients at risk of BC. The diagnosis of BC is confirmed by endoscopic transurethral resection. This procedure requires meticulous tumour excision, sampling of the underlying detrusor muscle and the flat urothelium or prostatic urethra in patients with high-grade cancers. The prognosis of BC depends upon tumour grade, stage, and other features.

Style APA, Harvard, Vancouver, ISO itp.

39

Small cell carcinomas: Causes, diagnosis and treatment. New York: Nova Biomedical Books, 2009.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

40

Goossens, Maria E., Frank Buntinx i Maurice P. Zeegers. Bladder and upper urinary tract cancer. Redaktor James W. F. Catto. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199659579.003.0070.

Pełny tekst źródła

Streszczenie:

Urinary bladder cancer (UBC) ranks ninth in worldwide cancer incidence. The most common histological type in Western countries is transitional cell carcinoma (TCC), while in Africa, a substantial proportion of squamous cell carcinomas (SCC) are observed related to the prevalence of infection with Schistosoma haematobium (bilharziasis). UBC has the highest per-patient lifetime cost for cancer in terms of healthcare expenditure compared to all other types of cancer. It is more frequent in men than in women and age is now widely accepted as the greatest single risk factor for developing UBC. The median age at diagnosis is 70 years. Cigarette smoking and specific occupational exposures, such as carcinogenic dyes for painters, are the main known causes of UBC.

Style APA, Harvard, Vancouver, ISO itp.

41

Hayat, M. A. Methods of Cancer Diagnosis, Therapy, and Prognosis: Ovarian Cancer, Renal Cancer, Urogenitary tract Cancer, Urinary Bladder Cancer, Cervical Uterine ... Leukemia, Multiple Myeloma and Sarcoma. Springer, 2016.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

42

Luo, Yongwen, Yi Zhang, Yu Xiao i Fang-Ming Deng, red. Molecular Biomarkers and Imaging Markers in the Prediction, Diagnosis, and Prognosis of Bladder Cancer. Frontiers Media SA, 2022. http://dx.doi.org/10.3389/978-2-88976-629-1.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

43

Ma, Chao, Rong Fan i Antoni Ribas, red. Cancer Immunotherapy & Immuno-monitoring: Mechanism, Treatment, Diagnosis, and Emerging Tools. Frontiers SA Media, 2014. http://dx.doi.org/10.3389/978-2-88919-380-6.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

44

Persad, Raj, red. Advances in the Scientific Evaluation of Bladder Cancer and Molecular Basis for Diagnosis and Treatment. InTech, 2013. http://dx.doi.org/10.5772/56665.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

45

Biomarkers in breast cancer: Molecular diagnostics for predicting and monitoring therapeutic effect. Totowa, N.J: Humana Press, 2006.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

46

Breit, Alfred, P. Lukas i A. Heuck. Tumor Response Monitoring and Treatment Planning: Advanced Radiation Therapy. Springer, 2012.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

47

Breit, Alfred. Tumor Response Monitoring and Treatment Planning: Advanced Radiation Therapy. Springer-Verlag Telos, 1992.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

48

Breit, Alfred, P. Lukas, A. Heuck, P. Kneschaurek i M. Mayr. Tumor Response Monitoring and Treatment Planning: Advanced Radiation Therapy. Springer London, Limited, 2013.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

49

Diagnosis, Evaluation, and Treatment of Non-Muscle Invasive Bladder Cancer: An Update, an Issue of Urologic Clinics. Elsevier - Health Sciences Division, 2013.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

50

National Bowel Cancer Screening Program monitoring report, 2008: 7 August 2006-30 June 2008. Canberra: Australian Institute of Health and Welfare, 2007.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

Oferujemy zniżki na wszystkie plany premium dla autorów, których prace zostały uwzględnione w tematycznych zestawieniach literatury. Skontaktuj się z nami, aby uzyskać unikalny kod promocyjny!